Breaking News Instant updates and real-time market news.

ETH

Ethan Allen

$30.45

-0.15 (-0.49%)

16:46
07/17/17
07/17
16:46
07/17/17
16:46

Ethan Allen reports Q4 preliminary EPS 41c-42c, consensus 50c

Net sales and projected earnings for the fourth quarter, ending June 30, were impacted by several factors, including very tough comparatives with the prior year quarter when retail net sales increased 7.6%, wholesale net sales increased 9.6%, and adjusted EPS increased 32.6%. Net sales in the prior year quarter also reflected shipments of new product introductions, which also resulted in stronger margins at the wholesale level. Additionally, during the current year fourth quarter, national advertising increased 27.5% over the prior year period, reflecting the Company's continued focus on brand building and driving traffic and sales."We look forward to discussing our progress and initiatives at the forthcoming Investor Meeting," said Farooq Kathwari, Chairman and CEO of Ethan Allen. "Fiscal 2017 was a 'year of action' where we completed many initiatives and also launched major new initiatives. Topics of the meeting will include the repositioning of our offerings, our expanded marketing, investments in new Design Centers around the country, investments in technology, the launch of the Ethan Allen Disney magical home program and the recent launch of the 'Ethan Allen design studio' on Amazon."Mr. Kathwari added, "During our fourth quarter, retail written orders in April decreased 7.1% and then progressively increased by 7.0% in May and 6.9% in June, resulting in a 1.9% increase for the quarter compared to the same period in the prior year. So far in July, written orders have continued a strong positive trend."

  • 19

    Jul

ETH Ethan Allen
$30.45

-0.15 (-0.49%)

01/26/17
01/26/17
DOWNGRADE

Neutral
Ethan Allen downgraded to Neutral at Dougherty
As previously reported, Dougherty downgraded Ethan Allen to Neutral from Buy following Q2 results. Analyst Jeremy Hamblin changed his views given a lack of visbility on the timing and impact on sales catalysts, including Disney Collection launch and US State Department contract, fewer new product introductions, tough 2H 17 comps, and significant downside risk to consensus FY17 and FY18 estimates.
01/26/17
01/26/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Johnson & Johnson (JNJ) downgraded to Market Perform from Outperform at Wells Fargo with analyst Larry Biegelsen saying the company's "disappointing" 2017 revenue guidance suggests its pharma business is facing more headwinds than he expected. J&J guided to underlying sales growth in 2017 of 3.0%-3.5%, which is a "sharp deceleration" from 7.4% underlying growth in 2016, Biegelsen tells investors in a research note. Biegelsen downgraded Johnson & Johnson before the company's announced acquisition of Actelion (ALIOF). He wrote, though, that any deal wouldn't likely close until late 2017. 2. United Technologies (UTX) downgraded to Hold from Buy at Argus with analyst John Eade citing valuation. 3. Ethan Allen (ETH) downgraded to Neutral from Buy at Dougherty with analyst Jeremy Hamblin changing his views given a lack of visibility on the timing and impact on sales catalysts, including Disney Collection launch and US State Department contract, fewer new product introductions, tough second half of 2017 comps, and significant downside risk to consensus fiscal 2017 and fiscal 2018 estimates. 4. Hasbro (HAS) downgraded to Neutral from Buy at Monness Crespi. 5. Mattel (MAT) downgraded to Neutral from Buy at MKM Partners with analyst Eric Handler saying the turnaround story has lost momentum as a slower than expected retail environment, fewer product reorders, and increased promotional activity resulted in disappointing year-end results. Handler expects foreign exchange headwinds, rising input costs, and an unfavorable product mix to continue into 2017. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/14/17
RAJA
03/14/17
UPGRADE
Target $36
RAJA
Strong Buy
Ethan Allen upgraded to Strong Buy from Market Perform at Raymond James
Raymond James analyst Budd Bugatch double upgraded Ethan Allen to Strong Buy from Market Perform saying sales comparisons get easier through 2017 while the retailer's remerchandising effort is behind it, thereby lowering the clearance markdowns. The analyst has a $36 price target for the shares.
03/14/17
03/14/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Disney (DIS) upgraded to Buy from Neutral at Guggenheim with analyst Michael Morris upgraded saying that he still sees strong potential upside despite the stock's move off its lows as the company enters another expansion cycle for its film, consumer products and parks businesses. The analyst is more cautious on the Networks business, both for Disney and the broader industry, but thinks that is reflected already in Disney shares. Morris raised his price target on Disney shares to $128 from $118. 2. Dick's Sporting (DKS) upgraded to Outperform from Peer Perform at Wolfe Research. 3. Quest Diagnostics (DGX) upgraded to Conviction Buy from Buy at Goldman with analyst Isaac Ro saying the company should be a key beneficiary as the U.S. healthcare system shifts the cost burden to the individual and creates price transparency for the first time. 4. Olympic Steel (ZEUS) and Reliance Steel (RS) were upgraded to Outperform from Neutral at Macquarie, while Worthington (WOR) was upgraded to Neutral from Underperform. 5. Ethan Allen (ETH) upgraded to Strong Buy from Market Perform at Raymond James with analyst Budd Bugatch double upgrading the company saying sales comparisons get easier through 2017 while the retailer's remerchandising effort is behind it, thereby lowering the clearance markdowns. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

FFKT

Farmers Capital Bank

$42.60

0.4 (0.95%)

05:12
10/19/17
10/19
05:12
10/19/17
05:12
Earnings
Farmers Capital Bank reports Q3 EPS 71c, consensus 58c »

Reports Q3 tangible book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$52.30

0.3 (0.58%)

05:11
10/19/17
10/19
05:11
10/19/17
05:11
Downgrade
Nike rating change  »

Nike downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

GSBC

Great Southern Bancorp

$56.80

0.25 (0.44%)

05:10
10/19/17
10/19
05:10
10/19/17
05:10
Earnings
Great Southern Bancorp reports preliminary Q3 EPS 82c, consensus 82c »

Reports preliminary Q3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

TERP

TerraForm Power

$13.58

0.62 (4.78%)

05:06
10/19/17
10/19
05:06
10/19/17
05:06
Initiation
TerraForm Power initiated  »

TerraForm Power…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABT

Abbott

$55.77

0.71 (1.29%)

05:04
10/19/17
10/19
05:04
10/19/17
05:04
Recommendations
Abbott analyst commentary  »

Abbott price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$187.15

-10.63 (-5.37%)

05:00
10/19/17
10/19
05:00
10/19/17
05:00
Recommendations
Allergan analyst commentary  »

Allergan price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 23

    Oct

  • 01

    Nov

  • 06

    Nov

MERC

Mercer

$13.50

-0.05 (-0.37%)

04:58
10/19/17
10/19
04:58
10/19/17
04:58
Upgrade
Mercer rating change  »

Mercer upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

ADBE

Adobe

04:57
10/19/17
10/19
04:57
10/19/17
04:57
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 06

    Nov

ANGI

Angie's List

04:57
10/19/17
10/19
04:57
10/19/17
04:57
Upgrade
Angie's List rating change  »

Angie's List…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

GWW

Grainger

$208.81

3.39 (1.65%)

04:57
10/19/17
10/19
04:57
10/19/17
04:57
Downgrade
Grainger rating change  »

Grainger downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

MZOR

Mazor Robotics

$58.55

3.57 (6.49%)

, NUVA

NuVasive

$54.18

0.47 (0.88%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Downgrade
Mazor Robotics, NuVasive rating change  »

Mazor Robotics downgraded…

MZOR

Mazor Robotics

$58.55

3.57 (6.49%)

NUVA

NuVasive

$54.18

0.47 (0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

MTCH

Match Group

$25.52

-0.56 (-2.15%)

, IAC

IAC

$124.60

-0.55 (-0.44%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Conference/Events
Jefferies Internet analysts hold an analyst/industry conference call »

Internet Analysts…

MTCH

Match Group

$25.52

-0.56 (-2.15%)

IAC

IAC

$124.60

-0.55 (-0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 08

    Nov

  • 09

    Nov

04:55
10/19/17
10/19
04:55
10/19/17
04:55
General news
Breaking General news story  »

Week of 10/13 EIA Natural…

04:55
10/19/17
10/19
04:55
10/19/17
04:55
General news
Breaking General news story  »

Week of 10/18 Fed Balance…

04:55
10/19/17
10/19
04:55
10/19/17
04:55
General news
Breaking General news story  »

Week of 10/9 Money Supply…

04:55
10/19/17
10/19
04:55
10/19/17
04:55
General news
Breaking General news story  »

6-Month Bill Announcement…

UBS

UBS

$17.26

0.02 (0.12%)

, CME

CME Group

$136.37

0.18 (0.13%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Conference/Events
Futures Industry Association to hold an expo »

33rd Annual FIA Futures…

UBS

UBS

$17.26

0.02 (0.12%)

CME

CME Group

$136.37

0.18 (0.13%)

NDAQ

Nasdaq

$74.60

-0.11 (-0.15%)

ICE

IntercontinentalExchange

$68.20

0.03 (0.04%)

CBOE

CBOE Holdings

$109.59

0.06 (0.05%)

BAC

Bank of America

$26.48

0.28 (1.07%)

GS

Goldman Sachs

$242.03

5.94 (2.52%)

JPM

JPMorgan

$97.99

0.37 (0.38%)

CS

Credit Suisse

$15.91

-0.11 (-0.69%)

C

Citi

$73.12

0.93 (1.29%)

AMZN

Amazon.com

$997.00

-12.13 (-1.20%)

MS

Morgan Stanley

$50.15

1.03 (2.10%)

WFC

Wells Fargo

$53.41

0.22 (0.41%)

AMTD

TD Ameritrade

$47.54

0.32 (0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 20

    Oct

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 27

    Oct

  • 02

    Nov

  • 02

    Nov

  • 05

    Nov

  • 07

    Nov

  • 07

    Nov

  • 07

    Nov

  • 20

    Nov

  • 29

    Nov

  • 15

    Jan

  • 27

    Feb

  • 18

    Mar

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

SNY

Sanofi

$49.53

-0.06 (-0.12%)

, PFE

Pfizer

$35.83

-0.37 (-1.02%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Conference/Events
Drug Information Association to hold a conference »

Metrics in…

SNY

Sanofi

$49.53

-0.06 (-0.12%)

PFE

Pfizer

$35.83

-0.37 (-1.02%)

ALKS

Alkermes

$51.09

-0.39 (-0.76%)

LLY

Eli Lilly

$85.73

-0.33 (-0.38%)

BMY

Bristol-Myers

$63.70

-0.48 (-0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 20

    Oct

  • 20

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 31

    Oct

  • 06

    Nov

  • 07

    Nov

  • 08

    Nov

  • 09

    Nov

  • 05

    Mar

VPG

Vishay Precision

$24.40

0.55 (2.31%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Conference/Events
Vishay Precision management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 07

    Nov

SCS

Steelcase

$15.30

0.1 (0.66%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Conference/Events
Steelcase management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 25

    Oct

  • 26

    Oct

04:55
10/19/17
10/19
04:55
10/19/17
04:55
General news
Philadelphia Fed Business Outlook Survey General Conditions Index to be reported at 08:30 »

October Philadelphia Fed…

SB

Safe Bulkers

$3.12

-0.01 (-0.32%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Conference/Events
Safe Bulkers management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

COST

Costco

$157.55

-0.83 (-0.52%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Conference/Events
Costco management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

04:55
10/19/17
10/19
04:55
10/19/17
04:55
General news
Breaking General news story  »

Kansas City Federal…

04:55
10/19/17
10/19
04:55
10/19/17
04:55
General news
Breaking General news story  »

Week of 10/15 Bloomberg…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.